344 related articles for article (PubMed ID: 32540348)
1. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
[TBL] [Abstract][Full Text] [Related]
2. Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance.
Drayton M; Kizhakkedathu JN; Straus SK
Molecules; 2020 Jul; 25(13):. PubMed ID: 32635310
[TBL] [Abstract][Full Text] [Related]
3. Rediscovery of antimicrobial peptides as therapeutic agents.
Ryu M; Park J; Yeom JH; Joo M; Lee K
J Microbiol; 2021 Feb; 59(2):113-123. PubMed ID: 33527313
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics.
Santos RS; Figueiredo C; Azevedo NF; Braeckmans K; De Smedt SC
Adv Drug Deliv Rev; 2018; 136-137():28-48. PubMed ID: 29248479
[TBL] [Abstract][Full Text] [Related]
5. A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides.
Browne K; Chakraborty S; Chen R; Willcox MD; Black DS; Walsh WR; Kumar N
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987946
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials for alternative antibacterial therapy.
Hemeg HA
Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptide polymers: no escape to ESKAPE pathogens-a review.
Mukhopadhyay S; Bharath Prasad AS; Mehta CH; Nayak UY
World J Microbiol Biotechnol; 2020 Aug; 36(9):131. PubMed ID: 32737599
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
[No Abstract] [Full Text] [Related]
9. Synergistic Effect of Propidium Iodide and Small Molecule Antibiotics with the Antimicrobial Peptide Dendrimer G3KL against Gram-Negative Bacteria.
Gan BH; Cai X; Javor S; Köhler T; Reymond JL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266085
[TBL] [Abstract][Full Text] [Related]
10. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.
Starr CG; Ghimire J; Guha S; Hoffmann JP; Wang Y; Sun L; Landreneau BN; Kolansky ZD; Kilanowski-Doroh IM; Sammarco MC; Morici LA; Wimley WC
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8437-8448. PubMed ID: 32241895
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterials: The New Antimicrobial Magic Bullet.
Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance.
Yang J; Zhao Y; Cao J; Gong C; Zuo J; Zhang N; Zhao Y
Int J Pharm; 2020 Aug; 586():119505. PubMed ID: 32526335
[TBL] [Abstract][Full Text] [Related]
13. Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance.
Lima PG; Oliveira JTA; Amaral JL; Freitas CDT; Souza PFN
Life Sci; 2021 Aug; 278():119647. PubMed ID: 34043990
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides: mechanism of action, activity and clinical potential.
Zhang QY; Yan ZB; Meng YM; Hong XY; Shao G; Ma JJ; Cheng XR; Liu J; Kang J; Fu CY
Mil Med Res; 2021 Sep; 8(1):48. PubMed ID: 34496967
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptides with symmetric structures against multidrug-resistant bacteria while alleviating antimicrobial resistance.
Zhong C; Zhang F; Yao J; Zhu Y; Zhu N; Zhang Y; Liu H; Gou S; Ni J
Biochem Pharmacol; 2021 Apr; 186():114470. PubMed ID: 33610592
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
17. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
[TBL] [Abstract][Full Text] [Related]
18. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
Medina E; Pieper DH
Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
[TBL] [Abstract][Full Text] [Related]
19. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
David AA; Park SE; Parang K; Tiwari RK
Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
[TBL] [Abstract][Full Text] [Related]
20. Chemically modified and conjugated antimicrobial peptides against superbugs.
Li W; Separovic F; O'Brien-Simpson NM; Wade JD
Chem Soc Rev; 2021 Apr; 50(8):4932-4973. PubMed ID: 33710195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
